These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2845624)

  • 1. Discriminative value of serum phosphatases in patients with prostatic carcinoma.
    Lämmel A; Krieg M; Becker H; Braun BE
    Urology; 1988 Oct; 32(4):293-300. PubMed ID: 2845624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of the prostate. II. Serum activity of acid phosphatase, prostatic acid phosphatase, LDH and its isoenzymes.
    Mráz J; Vrubel F; Hanselová M
    Int Urol Nephrol; 1979; 11(4):301-9. PubMed ID: 536179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
    Liewendahl K; Alfthan O; Ikonen T; Ruutu M; Rannikko S
    Scand J Urol Nephrol; 1984; 18(3):181-5. PubMed ID: 6494827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma.
    Desoize B; Amico S; Larbre H; Coninx P; Jardillier JC
    Clin Biochem; 1991 Oct; 24(5):443-6. PubMed ID: 1760884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma.
    Murphy GP; Reynoso G; Kenny GM; Gaeta JF
    Cancer; 1969 Jun; 23(6):1309-14. PubMed ID: 4306102
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of secretion pattern of human prostatic acid phosphatase: a reassessment.
    Dejter SW; Erickson BA; Lynch JH
    Urology; 1988 Feb; 31(2):125-8. PubMed ID: 3341096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 9. [DETERMINATION OF PROSTATIC PHOSPHATASE IN BLOOD SERUM].
    PINHEIRO J
    Hospital (Rio J); 1965 Feb; 67():283-92. PubMed ID: 14329942
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of radioimmunoassay and immunoradiometric assay for serum prostatic acid phosphatase.
    Sturgeon CM; Hussey AJ; Beynon L; Ritchie A; Chisholm GD; Micklem L; James K; Seth J
    Clin Chim Acta; 1986 Nov; 161(1):47-57. PubMed ID: 2434268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
    van Dieijen-Visser MP; Delaere KP; Gijzen AH; Brombacher PJ
    Clin Chim Acta; 1988 May; 174(2):131-40. PubMed ID: 2454767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective comparative study on serum acid phosphatases in the diagnostics of prostatic cancer.
    Seppänen J; Setälä E; Tunturi T
    Scand J Urol Nephrol; 1985; 19(4):247-51. PubMed ID: 2418497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroperitoneal metastatic disease due to carcinoma of the prostate: value of serum prostatic acid phosphatase in identifying retroperitoneal metastasis originating from carcinoma of prostate.
    BONNER CD; LYONS M
    AMA Arch Surg; 1954 Jul; 69(1):122-4. PubMed ID: 13170934
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.
    Killian CS; Emrich LJ; Vargas FP; Yang N; Wang MC; Priore RL; Murphy GP; Chu TM
    J Natl Cancer Inst; 1986 Feb; 76(2):179-85. PubMed ID: 2418245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare".
    Mackintosh J; Simes J; Raghavan D; Pearson B
    Br J Urol; 1990 Jul; 66(1):88-93. PubMed ID: 2203503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estracyt (NSC 89199) as a substrate for phosphatases in human serum.
    Tritsch GL; Shukla SK; Mittelman A; Murphy GP
    Invest Urol; 1974 Jul; 12(1):38-9. PubMed ID: 4366126
    [No Abstract]   [Full Text] [Related]  

  • 18. A solid-phase immunoadsorbent assay for serum prostatic acid phosphatase.
    Lee CL; Killian CS; Murphy GP; Chu TM
    Clin Chim Acta; 1980 Feb; 101(2-3):209-16. PubMed ID: 7357745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prostatic acid phosphatase levels in patients with carcinoma of the prostate.
    NOBLES ER; KERR WS; DUTOIT CH; ROURKE GM
    J Am Med Assoc; 1957 Aug; 164(18):2020-5. PubMed ID: 13462718
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
    el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
    Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.